Relay Therapeutics Inc. logo

Relay Therapeutics Inc.

RLAY | NASDAQ
Chart Builder DCF Calculator
$18.19
-$0.65 (-3.45%)
At close: Sep 21, 2026, 4:00 PM ET
$18.58
+$0.39 (+2.14%)
After-hours: Sep 21, 2026, 7:59 PM ET

Market Data

Market Cap
$4.13B
Enterprise Value
$3.9B
Beta
1.70
Average Volume
3.49M
Shares Outstanding (Diluted)
202.85M
Shares Change YoY
18.44%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US75943R1023

Price Performance

Price Change 1M
-5.1%
Price Change 3M
4.3%
Price Change 6M
89.5%
Price Change YTD
122.4%
Price Change 1Y
300.7%
Price Change 3Y
111.0%
Price Change 5Y
-50.5%
1M CAGR (ann.)
-4.6%
1Y CAGR (ann.)
360.6%
5Y CAGR (ann.)
-10.1%
All-Time CAGR
-9.6%

Valuation

PE Ratio
-11.59
Forward PE
N/A
PEG Ratio
-0.54
Forward PEG
-16.51
PS Ratio
385.14
Forward PS
222.60
PB Ratio
4.48
P/FCF Ratio
-15.14
P/Adj. FCF Ratio
-12.37
P/OCF Ratio
-17.32
EV/Sales
376.39
EV/EBIT
-13.62
EV/EBITDA
-13.58
EV/FCF
-14.79
Earnings Yield
-8.6%
FCF Yield
-6.6%
Adj. FCF Yield
-8.1%

Financial Health

Net Cash
$90.53M
Total Debt
$30.66M
Cash & Short-Term Investments
$121.19M
Total Assets
$967.46M
Current Ratio
18.27
Quick Ratio
18.27
Debt / Equity Ratio
0.03
Debt / EBITDA
-0.11
Debt / FCF
-0.12
OCF / Debt
-8.59
Interest Coverage
0.00
Altman Z-Score
28.97
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-566.6%
Operating Profit Margin
-2999.4%
EBITDA Margin
-2771.8%
Net Profit Margin
-2763.6%
FCF Margin
-2544.1%
Adj. FCF Margin
-3112.7%
SBC / Revenue
466.8%
SBC Impact (per share)
-22.4%

Returns

Return on Assets
-29.6%
Return on Equity
-42.3%
Return on Invested Capital
-33.7%
Return on Capital Employed
-33.9%
Return on Tangible Assets
-29.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
122.3%
Revenue CAGR 5Y
-34.3%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
23.8%
EPS CAGR 5Y
11.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
3.7%
FCF CAGR 5Y
-4.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
15
EPS Growth Next 3Y
8.1%
Revenue Growth Next 3Y
150.3%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.40
EPS Growth Est (next Q)
-7.0%
Revenue Est (next Q)
$1.62M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$26.25
Price Target Upside
44.3%

Cash Flow

Operating Cash Flow
$-263.32M
Free Cash Flow
$-263.32M
Adj. Free Cash Flow
$-322.16M
FCF Per Share
-$1.05
OCF Per Share
-$1.05
OCF/S Ratio
-2050.3%

Income Statement

Revenue
$10.35M
Gross Profit
$-58.64M
Operating Income
$-310.44M
EBITDA
$-286.88M
Net Income
$-286.04M
EPS (Diluted)
-$1.57
Revenue / Employee
$51.24K
Profit / Employee
$-1.42M
Employees
202

© 2026 bestshares.com. All rights reserved.